pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

21 catalysts · 10 approval · 10 grant · 1 recall

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 40 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-04-13×to 2026-04-13×clear all
type
  • approval10
  • grant10
  • recall1
therapy area

no tagged catalysts yet

Week of Apr 13, 2026

21
›04/13/2026recall
122d ago
Morovan recall: Cosmetics

Gel Nail Polish Remover (15ml)

full page →fda recalls ↗
›Apr 13, 2026approval122d agoOLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

Sponsor: MICRO LABS. Form: TABLET. Route: ORAL

full page →ALDACTAZIDE →fda approvals ↗
›Apr 13, 2026approval122d agoVANFLYTA (QUIZARTINIB DIHYDROCHLORIDE) — FDA approvalquizartinib dihydrochloride

Sponsor: DAIICHI SANKYO INC. Form: TABLET. Route: ORAL

full page →quizartinib dihydrochloride →fda approvals ↗
›Apr 13, 2026approval122d agoLAMOTRIGINE — FDA approvalAlembic Pharmaceuticals Inc

Sponsor: ALEMBIC PHARMS LTD. Form: TABLET. Route: ORAL

full page →fda approvals ↗
›Apr 13, 2026approval122d agoLAMOTRIGINE — FDA approvalAlembic Pharmaceuticals Inc

Sponsor: ALEMBIC PHARMS LTD. Form: TABLET. Route: ORAL

full page →fda approvals ↗
›Apr 13, 2026approval122d agoLURASIDONE HYDROCHLORIDE — FDA approvalLURASIDONE HYDROCHLORIDE

Sponsor: TORRENT. Form: TABLET. Route: ORAL

full page →LURASIDONE HYDROCHLORIDE →fda approvals ↗
›Apr 13, 2026approval122d agoLURASIDONE HYDROCHLORIDE — FDA approvalLURASIDONE HYDROCHLORIDE

Sponsor: TORRENT. Form: TABLET. Route: ORAL

full page →LURASIDONE HYDROCHLORIDE →fda approvals ↗
›Apr 13, 2026approval122d agoSPRAVATO (ESKETAMINE HYDROCHLORIDE) — FDA approvalJanssen Therapeutics

Sponsor: JANSSEN PHARMS. Form: SPRAY. Route: NASAL

full page →fda approvals ↗
›Apr 13, 2026approval122d agoARTESUNATE — FDA approvalARTESUNATE

Sponsor: AMIVAS. Form: POWDER. Route: INTRAVENOUS

full page →ARTESUNATE →fda approvals ↗
›Apr 13, 2026approval122d agoPIMOZIDE — FDA approvalPIMOZIDE

Sponsor: NOVITIUM PHARMA. Form: TABLET. Route: ORAL

full page →PIMOZIDE →fda approvals ↗
›Apr 13, 2026approval122d agoFILSPARI (SPARSENTAN) — FDA approvalsparsentan

Sponsor: TRAVERE. Form: TABLET. Route: ORAL

full page →sparsentan →fda approvals ↗
›Apr 13, 2026grant122d agoVANDERBILT UNIVERSITY MEDICAL CENTER — Immunogenicity and Safety of High-Dose vs. Standard-Dose Influenza Vaccines A...

AI grant. $887,964. PI: NATASHA Bassam HALASA

full page →nih reporter ↗
›Apr 13, 2026grant122d agoICAHN SCHOOL OF MEDICINE AT MOUNT SINAI — Niche Trajectory Analysis of Spatial Omics Data

HG grant. $2,583,834. PI: Guo-Cheng Yuan

full page →nih reporter ↗
›Apr 13, 2026grant122d agoFRED HUTCHINSON CANCER CENTER — AAV-delivered meganucleases for durable control of genital HSV disease

AI grant. $232,558. PI: KEITH R JEROME

full page →nih reporter ↗
›Apr 13, 2026grant122d agoUNIV OF NORTH CAROLINA CHAPEL HILL — RNA Ribosylation's Role in Viral RNA Biology and Innate Immunity

AI grant. $229,714. PI: Mark T Heise

full page →nih reporter ↗
›Apr 13, 2026grant122d agoCINCINNATI CHILDRENS HOSP MED CTR — Phenotype-Genotype Relationships in Tuberous Sclerosis

NS grant. $441,375. PI: Steve C Danzer

full page →nih reporter ↗
›Apr 13, 2026grant122d agoJOSLIN DIABETES CENTER — Targeting Renalase for early stage T1D treatment

DK grant. $826,321. PI: Accalia Fu

full page →nih reporter ↗
›Apr 13, 2026grant122d agoSTANFORD UNIVERSITY — Restoring Key Functions to the Industrialized Gut MicrobiomeStanford University

AT grant. $787,346. PI: Eric C Martens

full page →nih reporter ↗
›Apr 13, 2026grant122d agoYALE UNIVERSITY — Deciphering Residual Malaria Mechanisms in the Peruvian Amazon to Inform Nove...

AI grant. $580,306. PI: DIONICIA Baziliza GAMBOA VILELA

full page →nih reporter ↗
›Apr 13, 2026grant122d agoUNIVERSITY OF VERMONT & ST AGRIC COLLEGE — An Integrated Image-Enabled Computational Model for Lung Cancer Intratumoral ...

CA grant. $595,012. PI: Charles Matthew Kinsey

full page →nih reporter ↗
›Apr 13, 2026grant122d agoUNIVERSITY OF CINCINNATI — Consequences of mast cell activation and complement dysregulation in eosinoph...

AI grant. $207,995. PI: Simin Zhang

full page →nih reporter ↗
$TVTX60.21-1.12%